Additionally, S100A4 and galectin-1 were identified as overexpressed both in the murine CT26-bearing spleen and liver, and these were previously reported to contribute to disease progression and poor prognosis in human CRC patients. The gene discussed is S100A4; the disease is colorectal carcinoma.